Please use this identifier to cite or link to this item: http://hdl.handle.net/10790/3015

Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014

File Description SizeFormat 
TCA Midyear Poster 2016 PDF_So_Taira.pdfpdf3.87 MBAdobe PDFView/Open

Full Item Record

DC FieldValueLanguage
dc.contributor.authorSo, Nadine W.-
dc.contributor.authorTaira, Deborah-
dc.date.accessioned2017-04-11T19:46:38Z-
dc.date.available2017-04-11T19:46:38Z-
dc.date.issued2017-04-11-
dc.identifier.urihttp://hdl.handle.net/10790/3015-
dc.descriptionPdfen_US
dc.description.abstractTricyclic antidepressants were the primary pharmacologic treatment for depression in the United States from the 1960s to the late 1980s. Since then, other classes of antidepressants, such as Selective Serotonin Reuptake Inhibitors, have replaced its use as first-line agents due to their more favorable side-effect profile and proven equal efficacy. Tricyclic antidepressants are included in the Beers Criteria because of their potentially harmful side effects in the elderly (e.g. cognitive impairment, delirium, sedation, and orthostatic hypotension). The purpose of this study is to evaluate the changes in prescribing of tricyclic antidepressants from 2013 to 2014 in Medicare beneficiaries.en_US
dc.format.extent1 posteren_US
dc.language.isoen-USen_US
dc.rightsThis item is licensed under a Creative Commons License.en_US
dc.subjectAntidepressive Agents, Tricyclicen_US
dc.subjectMedicare Part Den_US
dc.subjectInappropriate Prescribingen_US
dc.subjectPhysicians' practice patternsen_US
dc.titleMedicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014en_US
dc.typeImageen_US
dc.typeOtheren_US
dc.type.dcmiTexten_US
Appears in Collections:DKICP Student Research Projects



This item is licensed under a Creative Commons License Creative Commons